Search Results - "Vrijsen, K.R."

Suppression of T cells by mesenchymal and cardiac progenitor cells is partly mediated via extracellular vesicles by van den Akker, F., Vrijsen, K.R., Deddens, J.C., Buikema, J.W., Mokry, M., van Laake, L.W., Doevendans, P.A., Sluijter, J.P.G.

“…Adverse remodeling after myocardial infarction (MI) is strongly influenced by T cells. Stem cell therapy after MI, using mesenchymal stem cells (MSC) or…”
Get full text

Cardiomyocyte progenitor cell‐derived exosomes stimulate migration of endothelial cells by Vrijsen, K. R., Sluijter, J. P. G., Schuchardt, M. W. L., Van Balkom, B. W. M., Noort, W. A., Chamuleau, S. A. J., Doevendans, P. A. F. M.

“…•  Cell therapy •  The paracrine hypothesis •  Exosomes •  Collection CMPC secreted exosomes •  Conditioned medium and exosomes in in vitro scratch wound assay…”
Get full text

Cell therapy for ischaemic heart disease: focus on the role of resident cardiac stem cells by Chamuleau, S. A. J., Vrijsen, K. R., Rokosh, D. G., Tang, X. L., Piek, J. J., Bolli, R.

“…Myocardial infarction results in loss of cardiomyocytes, scar formation, ventricular remodelling, and eventually heart failure. In recent years, cell therapy…”
Get full text